Antibacterial activity of the marine sponge constituent cribrostatin 6

Journal of Medical Microbiology

Volumn 53, Issue 1, 2004, Pages 61-65

  Pettit, Robin K ^a   Fakoury, Bridget R ^a   Knight, John C ^a   Weber, Christine A ^a   Pettit, George R ^a,b   Cage, Gary D ^c   Pon, Sandy ^a  

^a Cancer Research Institute   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c PHOENIX CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CRIBROSTATIN 6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; GRAM POSITIVE BACTERIUM; MAXIMUM TOLERATED DOSE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SPONGE (PORIFERA); SPONTANEOUS MUTATION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL ASSAY; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIA; HUMANS; HYDROGEN-ION CONCENTRATION; ISOQUINOLINES; MICE; MICROBIAL SENSITIVITY TESTS; MUTATION; PORIFERA; RANDOM ALLOCATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 1542635310     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05250-0     Document Type: Article

References (11)

1. Amsterdam, D. (1996). Susceptibility testing of antimicrobials in liquid media. In Antibiotics in Laboratory Medicine, 4th edn, pp. 52-111. Edited by V. Lorian. Baltimore: Williams & Wilkins.
2. Calabresi, P., Goulette, F. A. & Darnowski, J. W. (2001). Taurolidine: cytotoxic and mechanistic evaluation as a novel antineoplastic agent. Cancer Res 61, 6816-6821.
3. Cardenas, M. E., Cruz, M. C., Del Poeta, M., Chung, N., Perfect, J. R. & Heitman, J. (1999). Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. Clin Microbiol Rev 12, 583-611.
4. Doerr, G. V., Heilmann, K. P., Huynh, H. K., Rhomberg, P. R., Coffman, S. L. & Brueggemann, A. B. (2001). Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 45, 1721-1729.
5. Greenwood, B. (1999). The epidemiology of pneumococcal infection in children in the developing world. Philos Trans R Soc Lond B Biol Sci 354, 777-785.
6. Liu, Y., Ryan, M. E., Lee, H. M., Simon, S., Tortora, G., Lauzon, C., Leung, M. K. & Golub, L. M. (2002). A chemically modified tetracycline (CMT-3) is a new antifungal agent. Antimicrob Agents Chemother 46, 1447-1454.
7. Lokeshwar, B. L., Houston-Clark, H. L., Selzer, M. G., Block, N. L. & Golub, L. M. (1998). Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer. Adv Dent Res 12, 97-102.
8. Musher, D. M. (1992). Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 14, 801-807.
9. NCCLS (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. Villa Nova, PA: National Committee for Clinical Laboratory Standards.
10. Pettit, G. R., Knight, J. C., Collins, J. C., Herald, D. L., Pettit, R. K., Boyd, M. R. & Young, V. G. (2000). Antineoplastic agents 430. Isolation and structure of cribrostatins 3, 4, and 5 from the Republic of Maldives Cribrochalina species. J Nat Prod 63, 793-798.
11. Pettit, G. R., Collins, J. C., Knight, J. C., Herald, D. L., Nieman, R. A., Williams, M. D. & Pettit, R. K. (2003). Antineoplastic agents 485. Isolation and structure of cribrostatin 6, a dark blue cancer cell growth inhibitor from the marine sponge Cribrochalina sp. J Nat Prod 66, 544-547.